Abstract. Cell therapy using mesenchymal stem cells provides a promising approach for the treatment of intervertebral disc degeneration (IDD). In recent years, human nucleus pulposus mesenchymal stem cells (NPMSCs) have been identified in nucleus pulposus tissue and displayed great potential for the regeneration of IDD. However, biological differences between non-degenerative and degenerative nucleus pulposus-derived NPMSCs have remained to be defined. The aim of the present study was to compare the biological characteristics of human NPMSCs derived from non-degenerative and degenerative nucleus pulposus. NPMSCs were isolated from non-degenerative and degenerative nucleus pulposus, which were assessed using the Pfirrmann grading system. The biological characteristics of the NPMSCs, including the expression of surface markers, multipotent differentiation, colony formation, chemotactic cell migration, cell activity and stemness gene expression were compared. It was found that NPMSCs could be obtained from non-degenerative and degenerative human nucleus pulposus. However, degenerative nucleus pulposus-derived NPMSCs displayed decreased ability of colony formation, chemotactic migration, cell activity and expression of stemness genes compared with non-degenerative nucleus pulposus-derived NPMSCs. Therefore, NPMSCs derived from non-degenerative and degenerative nucleus pulposus show different biological behaviors. The degenerative status of nucleus pulposus tissue should be considered when selecting NPMSCs as a source for clinical application.
Introduction
Lower back and neck pain are the major causes of disability and impose a huge economic burden on health care systems (1, 2) . In the USA, expenditures for patients with spine problems were $85.9 billion in 2005, higher than those for numerous other causes of disability, including arthritis, and potentially fatal diseases such as cancer, while the prevalence remains to increase rapidly (2) . Intervertebral disc degeneration (IDD) is the major cause of lower back and neck pain (3, 4) . The normal intervertebral disc (IVD) is composed of three distinct components: The central hyper-hydrated nucleus pulposus, the outer annulus fibrosis, and the upper and lower cartilaginous endplates (4) . Although the causes of IDD remain to be largely elusive, a decrease in the function and number of nucleus pulposus cells (NPCs) is known to be an initial trigger of IDD (5, 6) . Various operative methods, including spinal fusion and artificial disc replacement, have been used to treat degenerative disc diseases, and have shown satisfactory results in alleviating pain. However, they are associated with certain complications, including prosthetic disc migration, extrusion or failure as well as accelerated degeneration of the IVDs adjacent to the fusion (7, 8) . The most important disadvantage of these treatments is that they are aimed to alleviate the symptoms of IDD, but do not target the underlying disease itself. None of them aims to restore the biological function of the disc, or to retard or reverse IDD (3, 9) .
Cell therapy using mesenchymal stem cells (MSCs) has provided promising procedures for treating IDD in the field of regenerative medicine (3) . Numerous stem cell types have been used in the field of cell transplantation for the treatment of IDD, such as bone marrow-derived stem cells (BMSCs) (10) , adipose-derived MSCs (ADMSCs) (11) , human umbilical tissue-derived cells (12) and synovium-derived stem cells (13 (14, 15) . Certain studies have reported that these stem cells lack viability, proliferation and matrix biosynthesis under conditions resembling the IVD microenvironment, which negatively influences the biological and metabolic vitality of stem cells and impairs their repair potential (16, 17) . In recent years, increasing evidence supported the existence of nucleus pulposus MSCs (NPMSCs) in the nucleus pulposus (18) (19) (20) (21) (22) (23) (24) . They possess a similar capacity of chondrogenic differentiation to that of BMSCs (18) and have better adaptability to the harsh IVD microenvironment than ADMSCs (24) . This suggests that NPMSCs may be a good candidate cell for IVD regeneration by cell therapy. Previous studies have proved that NPMSCs can be isolated from normal and degenerative nucleus pulposus (18) (19) (20) (21) (22) (23) (24) . However, the biological properties of stem cells are crucial for the regenerative effects of cell therapy. To the best of our knowledge, whether non-degenerative (ND)-NPMSCs and degenerative (D)-NPMSCs have different biological characteristics has not been clarified. The present study aimed to compare the biological characteristics of human NPMSCs derived from non-degenerative and degenerative nucleus pulposus.
Materials and methods
Sample collection and group allocation. All procedures in the present study were approved by the Ethical Committee of Navy General Hospital (Beijing, China) and informed consent was obtained from all donors. All of the NP samples were obtained from 12 patients who underwent routine surgery for lumbar disorders between January and April 2015 in the Department of Orthopaedics, Navy General Hospital (Beijing, China). Samples were allocated to non-degenerative group (Pfirrmann grade I and II) and degenerative group (Pfirrmann grade IV and V) according to the Pfirrmann grading system (25) . Therein, samples from 4 patients with congenital scoliosis and 2 patients with lumbar burst fracture were assigned to the non-degenerative group (NDG) and samples from 6 patients with lumbar intervertebral disc degeneration were assigned to degenerative group (DG). All of the assays described below were based on these two groups (NDG and DG).
Isolation and culture of NPMSCs. Tissue samples from the NDG and DG were washed 3 times with PBS and mechanically fragmented into 1 mm 3 sections with ophthalmic scissor. Anulus fibrous, endplates, vessels and ligaments surrounding the NP were removed as much as possible. Subsequently, tissue fragments were digested with 0.2% (m/v) collagenase II (Sigma-Aldrich; Merck KGaG, Darmstadt, Germany) for 6 h at 37˚C. Primary cells were obtained after filtering through cell strainers with a pore size of 70 µm, resuspended in Dulbecco's modified Eagle's medium-low glucose (DMEM-LG) supplemented with 10% fetal bovine serum (FBS) (both from Sigma-Aldrich; Merck KGaG), and were then seeded in 25 cm 2 flasks at a density of 1x10 5 /ml. Cells were cultured in an incubator at 37˚C in a humidified atmosphere containing 5% CO 2 and passaged upon reaching 80% confluence. The medium was changed every 3 days and the morphology of NPMSCs from different NP samples was observed under an inverted microscope. For further study, NPMSCs at passage 3 were resuspended in DMEM at the density required and subjected to various assays.
Flow cytometric analysis. Flow cytometric analysis was performed with an FC 500 flow cytometry instrument (Beckman Coulter, Brea, CA, USA). According to the standards proposed by the International Society For Cellular Therapy (ISCT), cell surface markers including CD90, CD105, CD73, human leukocyte antigen-antigen D related (HLA-DR), CD45, CD34 were used for identification of the MSC as phenotype in the present study (26) . Of these, CD90, CD105, and CD 73 are highly expressed in MSCs, while HLA-DR, CD45 and CD34 are highly expressed in hematopoietic stem cells. In brief, 2x10 5 NPMSCs from each group were stained with phycoerythrin-conjugated monoclonal antibodies. 
Multipotent differentiation.
NPMSCs from various groups were induced to differentiate toward osteogenic, adipogenic and chondrogenic linages. All of the procedures were in accordance with the instructions provided by the manufacturers of the differentiation media.
Osteogenic differentiation. NPMSCs at passage 3 were resuspended at the density of 5x10 3 /ml and seeded in 6-well plates. Osteogenic medium (Cyanogen, Palo Alto, CA, USA) was added when cells reached 60% confluence and changed every 3 days. After induction for 28 days, culture medium was removed and cells were fixed with 4% paraformaldehyde for 15 min. Fixed MSCs were then stained with alizarin red (Sigma-Aldrich; Merck KGaG) and observed under an inverted microscope.
Adipogenic differentiation. NPMSCs at passage 3 were seeded in 6-well plates at a density of 2x10 3 /ml. Adipogenic medium A (Cyanogen) was added when cells reached 95% confluence and was replaced by Adipogenic medium B (Cyanogen) after 3 days. After 24 h, adipogenic medium B was replaced by adipogenic medium A, and this cycle was repeated 3 times. The adipogenic induction was then maintained by incubation in adipogenic medium A. Oil red-O staining (Sigma-Aldrich; Merck KGaG) was performed after induction for 28 days.
Chondrogenic differentiation. NPMSCs at passage 3 were resuspended in complete DMEM at a density of 5x10 5 /ml. To obtain a cell pellet, ~0.5 ml cell suspension (containing 2.5x10 5 cells) was pipetted into a 15-ml centrifuge tube and centrifuged at 600 x g for 5 min. The supernatant was then removed and 1 ml chondrogenic medium (Cyanogen) was gently added to the tube without agitation. After culture for 28 days, cell pellets were fixed with 4% paraformaldehyde for 30 min and stained with alcian blue (Sigma-Aldrich; Merck KGaG).
Colony formation assay. Cells at the third passage (1,000/cm 2 ) were seeded in a 6-well plate and cultured with DMEM supplemented with 10% FBS. After culture for 14 days, cells were fixed with 4% paraformaldehyde for 15 min and stained with 1% crystal violet. Following washing with triple distilled water for 3 times, colonies that consisted of >30 nucleated cells were counted under an inverted microscope.
Chemotactic migration assay. Chemotactic migration was evaluated by a standard Transwell assay. Cells (2x10 4 /100 µl) were seeded into the upper chamber with semipermeable membrane (pore size, 5 µm). Subsequently, each of the lower wells of the 24-well plate was filled with complete DMEM. After incubation for 12 h, cells remaining on the upper surface of the membrane was wiped off with a cotton swab and cells, which had migrated to the lower surface, were fixed with 4% paraformaldehyde for 15 min and stained with 1% crystal violet. The migrated cells were quantified as the cell number per field of view.
Cell proliferative activity assay. Cell proliferative activity was assessed by a Cell Counting Kit-8 (CCK-8). In brief, cells at passage 3 were resuspended at a density of 5x10 4 /ml and 100 µl cell suspension was added into each well of 96-well plate. At designated time-points (4 h, 1, 3, 5, 7, 9, 11 and 13 days), 10 µl CCK-8 solution was added into the 96-well plate and incubated at 37˚C for 2 h. The optical density (OD) value was analyzed using a spectrophotometer (UV762; Yoke Instrument, Co., Ltd., Shanghai, China). For each time-point, all experiments were performed three times in triplicate.
Reverse-transcription quantitative polymerase chain reaction (RT-qPCR) analysis of stemness genes. The expression of the stemness genes octamer-binding transcription factor 4 (Oct-4) and Nanog was determined by RT-qPCR. In brief total RNA was extracted using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc., MA, USA) according to the manufacturer's instructions. High Capacity cDNA Reverse Transcription kit (Thermo Fisher Scientific, Inc., MA, USA) was used to reverse transcribe RNA into cDNA. PCR was then performed following the manufacturer's instructions, as follows: 94˚C for 60 sec, 37˚C for 60 sec and 72˚C for 2 min for 30 cycles. GADPH was used as the internal control; results were quantified as previously described (27) . The sequences of the primers (Sanong Biotech Co., Ltd., Shanghai, China) are listed in Table I .
Statistical analysis. SPSS 19.0 software (IBM, Armonk, NY, USA) was used for statistical analysis. Values are expressed as the mean ± standard deviation. Statistical analysis was performed using analysis of variance. P<0.05 was considered to indicate a statistically significant difference.
Results

Stem cell marker expression on D-and ND-NPMSCs.
NPMSCs from the NDG and DG highly expressed CD105, CD90 and CD73 (characteristic cell surface marker of MSCs) and did not express CD45, CD34 and HLA-DR (characteristic cell surface markers of hematopoietic stem cells). In the NDG and DG, the positive expression rate for CD105, CD90 and CD73 was >95% for all, respectively, and the positive expression rate for CD45, CD34 and HLA-DR was <4% (Fig. 1) . 
D-and ND-NPMSCs have a comparable multipotent differentiation capacity.
At passage 3, undifferentiated ND-NPMSCs and D-NPMSCs displayed elongated and spindle-like shapes ( Fig. 2A and B) . Alizarin red staining showed deposition of large amounts of calcium nodules in ND-NPMSCs and D-NPMSCs ( Fig. 2C and D) . A large amount of lipid droplets deposited in cells subjected to Oil red-O staining indicated that ND-NPMSCs and D-NPMSCs differentiate into adipocytes after culture in adipogenic medium for 28 days (Fig. 2E and F) . Chondrogenic differentiation was assessed by alcian blue staining after culture of cell pellets with chondrogenic medium. ND-NPMSCs and D-NPMSCs were positive for alcian blue staining ( Fig. 2G and H) . These results demonstrated that ND-NPMSCs and D-NPMSCs have a comparable capacity for multipotent differentiation.
ND-NPMSCs have a higher clonogenic and migratory capacity than D-NPMSCs.
The clonogenicity of NPMSCs was evaluated after culture for 14 days (Fig. 3A-C) . The number of colonies in each well of a 6-well plate was 315.5±41.87 in the ND-NPMSC and 79.83±15.72 in the D-NPMSC group, and the difference between the two groups was significant (P<0.05). A Transwell assay was used to evaluate the capacity of NPMSCs for chemotactic migration, showing that the number of ND-NPMSCs migrated to the lower from the upper surface was nearly two times that of D-NPMSCs (P<0.05; Fig. 3D-F) .
ND-NPMSCs have a higher proliferative rate than D-NPMSCs.
The proliferative activity of NPMSCs was assessed using aCCK-8 assay. The results demonstrated that the cell proliferative activity of ND-NPMSCs and D-NPMSCs was not significantly different from 4 h to 3 days (P>0.05). However, the proliferative activity of ND-NPMSCs was higher than that of D-NPMSCs from days 5-13 (P<0.05; Fig. 4 ).
ND-NPMSCs show a higher expression of stemness genes than D-NPMSCs.
The results of the RT-qPCR analysis showed that in ND-NPMSCs, the gene expression levels of Oct4 and Nanog were higher than those in D-NPMSCs (P<0.05). The relative expression of Oct4 and Nanog in ND-NPMSCs was 4.63±1.17 and 7.36±1.19 times that in D-NPMSCs, respectively (P<0.05; Fig. 5 ).
Discussion
MSCs are attractive sources of stem cells for regenerative medicine, possessing self-renewal and multi-lineage differentiation potentials (28) . MSCs have been successfully isolated from numerous adult tissues (28) , including bone marrow (10), adipose tissue (11), umbilical tissue (12) and synovium (13) . NPMSCs have been isolated from nucleus pulposus and provide a promising approach for the treatment of IDD. In 2007, Risbud et al (29) isolated stem cells from the degenerative intervertebral disc, which were characterized by MSCs surface marker analysis and displayed osteogenic and adipogenic differentiation capacity. Therefore, these cells were defined as resident skeletal progenitor cells in the IVD. Subsequently, Brisby et al (30) identified progenitor cells inside the IVD by immunohistochemical staining. In addition, Blanco et al (18) successfully isolated nucleus pulposus progenitor cells by using standard MSC culture medium, demonstrated their multilineage differentiation potential and identified their immunophenotype, which were all characteristics of MSCs. Based on the minimal criteria for defining MSCs proposed by ISCT, Blanco et al (18) defined these multipotent cells as NPMSCs.
In the present study, the same method (18) was used to isolate and culture cells with the same characteristics from 6 non-degenerative and 6 degenerative nucleus pulposus tissues. NPMSCs in each of the two groups attached well and the positive rate of CD105, CD90 and CD73 surpassed 95% while that of CD45, CD34 and HLA-DR was >4%. ND-NPMSCs and D-NPMSCs had multilineage differentiation potential toward osteogenesis, chondrogenesis and adipogenesis. All of these results confirmed the feasibility of the isolation and culture NPMSCs from non-degenerative and degenerative nucleus pulposus.
Along with aging and accumulation of noxious stimuli, the intervertebral disc is gradually degenerated due to the reduction of activity as well as the amount and production of extracellular matrix by inherent cells (31, 32) . However, few studies have compared the biological characteristics of NPMSCs isolated from human non-degenerative and degenerative nucleus pulposus tissues. In the present study, clonogenic and migratory capacity were performed, and results indicated that ND-NPMSCs exhibited better capacities, compared with D-NPMSCs. Furthermore, a CCK-8 assay was used to compare cell proliferative activity of ND-NPMSCs and D-NPMSCs. At 5, 7, 9, 11 and 13 days after cell seeding, the OD value of D-NPMSCs was obviously higher than that of D-NPMSCs, which directly reflected that the cell proliferative activity of ND-NPMSCs was significantly higher than that of D-NPMSCs. It was conjectured that this difference maybe attributed to the accumulated injury in the disc with long-term stimulus of stress and inflammatory cytokines in the process of degeneration.
MSCs possess the capacity of self-renewal and multilineage differentiation (33) . Numerous studies have found that the capacity of proliferation and differentiation of adult stem cells decreased with age and degeneration, which may result from lessened expression of genes regulating the maintenance of stemness of stem cells (34) (35) (36) (37) . Furthermore, expression of stemness genes has an important role in the regulation of multilineage differentiation of stem cells and decreases with cell differentiation (38) (39) (40) . Tsai et al (41) also found that Oct4 and Nanog genes were highly expressed in adult MSCs, and that proliferation and differentiation of MSCs decreased after knockout of the Oct4 and Nanog genes. In the present study, RT-qPCR analysis showed that relative expression levels of Oct4 and Nanog in the NDG were 4.63 and 7.36 times those in the DG. These results suggested that ND-NPMSCs displayed better self-renewal and multilineage differentiation capacity than D-NPMSCs. The adverse stimulus in the process of degeneration may be the major reason for these findings.
In conclusion, the present study demonstrated that NPMSCs isolated from non-degenerative nucleus pulposus tissue exhibited better in stem cell marker expression, clonogenic and migratory capacity, proliferative rate and expression of stemness genes, compared with NPMSCs isolated from degenerative nucleus pulposus tissue. Therefore, the degenerative status of nucleus pulposus tissue should be considered when selecting a source of NPMSCs for clinical application.
